Systematic Identification of the Functional lncRNAs During H7N9 Avian Influenza Virus Infection in Mice. [PDF]
Wang G +8 more
europepmc +1 more source
Characteristics and mechanisms of liver injury caused by emerging infectious diseases. [PDF]
Cheng Y, Zheng X.
europepmc +1 more source
Expert consensus on imaging diagnosis of human infection with avian influenza. [PDF]
Wang FR +43 more
europepmc +1 more source
Atypical H7N9 avian influenza.
Beuy, Joob, Viroj, Wiwanitkit
openaire +1 more source
TRIM45 restricts influenza virus infection through modulating the chaperone-mediated autophagic degradation of viral PB2 protein. [PDF]
Wang Y +12 more
europepmc +1 more source
Intranasal replicon vaccine establishes mucosal immunity and protects against H5N1 and H7N9 influenza. [PDF]
Ykema MR +20 more
europepmc +1 more source
Rapid clinical validation of an RNA/DNA hybrid tagmentation-based metagenomic workflow for respiratory RNA virus detection. [PDF]
Ma X, Guo S, Feng Y, Su M, Wei F, Liu X.
europepmc +1 more source
Establishment and application of EmDEA, a rapid on-site nucleic acid detection method for parrot bornavirus type 4. [PDF]
Qian Y +15 more
europepmc +1 more source
A cross-sectional study of avian influenza virus in poultry markets of Guangdong China, 2025. [PDF]
Deng W +13 more
europepmc +1 more source
Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus [PDF]
The recent emergence of severe human illness caused by avian-origin influenza A(H7N9) viruses in China has precipitated a global effort to rapidly develop and test vaccine candidates. To date, non-A(H7N9) H7 subtype influenza vaccine candidates have been
Gregory Glenn
exaly +2 more sources

